We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Uses Bio-Printed ‘Patches’ to Repair Damaged Heart Tissue

By HospiMedica International staff writers
Posted on 14 Mar 2023

Cardiovascular disease remains the leading cause of death globally. More...

One of the associated complications of heart disease is heart failure, in which inadequate blood supply to an affected region causes the death of heart tissue. This often necessitates life-long medication, and end-stage heart failure patients may subsequently be enrolled on a waiting list for a heart transplant. Now, researchers have demonstrated the potential of bio-engineered heart tissues in promoting the safe and effective recovery of patients recovering from damage due to an extensive heart attack.

The cutting-edge technology developed by researchers from The University of Technology Sydney (UTS, Sydney, Australia) fabricates personalized ‘bio-inks’ utilizing stem cells obtained from a patient's body. These "bio-inks" are subsequently utilized for 3D-printing cardiac tissues to repair the regions affected by dead tissues resulting from a heart attack. Further testing for the long-term effects of this technology is underway before it enters clinical trials.

“Our study demonstrated that bio-engineered patches were the best and most robust treatment of heart failure – patches generated with other approaches either did not induce any improvement or the improvement was inconsistent,” said Dr. Carmine Gentile, head of the Cardiovascular Regeneration Group at UTS. “Our bio-engineered patches promise to be safer, more consistent, and cost-effective for the patient. Because this technology will enable patients to use their own stem cells to create the heart ‘patches’, not only can they potentially dramatically reduce the trauma and cost of a heart transplant, but also avoid hurdles such as a body rejecting donor tissues.”

Related Links:
The University of Technology Sydney


New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Hybrid Arch Device
Neo EDE
New
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.